Protective effects of cyclophosphamide, cyclosporin A and FK506 against antigen-induced lung eosinophilia in guinea-pigs
Tóm tắt
A close association has been recognized between activated T cells and eosinophils in asthma, albeit circumstantial. The present study attempted to investigate this relationship in an animal model of lung eosinophilia using the new generation of T cell-selective immunosuppressants, cyclosporin A and FK506, compared with the myelotoxic immunosuppressive agent cyclophosphamide. Antigen challenge of ovalbumin-sensitized guinea-pigs resulted in a lung eosinophilia which was assessed by bronchoalveolar lavage. All three agents caused a marked suppression of lung eosinophilia at 24 h post-challenge when the compounds were administered at the time of sensitization but not when administered for 3 days before lavage. However, the lung eosinophilia at 72 h post-challenge was reduced significantly by FK506 and by cyclophosphamide, but not by cyclosporin A, when the drugs were administered for 3 days, before lavage. These results strongly suggest the involvement of T cells in antigen-induced late phase (72 h) eosinophilia in guinea-pigs but not at 24 h. The effects of cyclophosphamide were always associated with a reduction in circulating white cell counts, whereas cyclosporin A and FK506 showed no myelotoxic properties. These results suggest the potential therapeutic use of selective, non-cytotoxic immunosuppressive agents in asthma.
Từ khóa
Tài liệu tham khảo
Denburg, 1989, Basophil mast cell and eosinophil growth and differentiation factors in human allergic disease, Clin Exp Allergy, 19, 249, 10.1111/j.1365-2222.1989.tb02379.x
Owen, 1987, Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts, J Exp Med, 168, 129, 10.1084/jem.166.1.129
Lopez, 1988, Recombinant human IL5 is a selective activator of human eosinophil function, J Exp Med, 167, 219, 10.1084/jem.167.1.219
Rothenberg, 1988, Human eosinophils have prolonged survival, enhanced functional properties and become hypodense when exposed to human interleukin-3, J Clin Invest, 81, 1986, 10.1172/JCI113547
Yamaguchi, 1988, Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival, J Exp Med, 167, 1737, 10.1084/jem.167.5.1737
Corrigan, 1988, T lymphocyte activation in acute severe asthma, Lancet, i, 1129, 10.1016/S0140-6736(88)91951-4
Azzawi, 1990, Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma, Am Rev Resp Dis, 142, 1407, 10.1164/ajrccm/142.6_Pt_1.1407
Corrigan, 1990, T lymphocyte activation in acute severe asthma, Am Rev Resp Dis, 141, 970, 10.1164/ajrccm/141.4_Pt_1.
Gleich, 1984, Asthma III. Pathophysiology, immunopharmacology and treatment, 195
Durham, 1985, Eosinophils, bronchial hyperreactivity and late asthmatic reactions, Clin Allergy, 15, 411, 10.1111/j.1365-2222.1985.tb02290.x
Bousquet, 1990, Eosinophilic inflammation in asthma, N Engl J Med, 323, 1033, 10.1056/NEJM199010113231505
Frew, 1988, The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man, J Immunol, 141, 4158
Gonzalez, 1987, Allergen-induced recruitment of bronchoalveolar helper (OKT4) and suppressor (OKT8) T-cell in asthma, Am Rev Resp Dis, 136, 600, 10.1164/ajrccm/136.3.600
Frew, 1990, T lymphocytes and eosinophils in allergen-induced late-phase asthmatic reactions in the guinea-pigs, Am Rev Resp Dis, 141, 407, 10.1164/ajrccm/141.2.407
Martinet, 1988, Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis, Am Rev Resp Dis, 138, 1242, 10.1164/ajrccm/138.5.1242
Mullarkey, 1986, Methotrexate in the treatment of steroid-dependent asthma, Ann Allergy, 56, 347
Mullarkey, 1988, Methotrexate in the treatment of corticosteroid-dependent asthma, N Engl J Med, 318, 603, 10.1056/NEJM198803103181004
Pacheco, 1985, Azathioprine treatment of chronic pulmonary sarcoidosis, Sarcoidosis, 8, 107
Borel, 1976, Biological effects of cyclosporin A: a new anti-lymphocytic agent, Agents Actions, 6, 468, 10.1007/BF01973261
Kino, 1987, FK506, a novel immunosuppressant isolated from A. streptomyces. II Immunosuppressant effect of FK506 in vitro, J Antibiotics, XL, 1256, 10.7164/antibiotics.40.1256
Hutson, 1988, Early and late-phase bronchoconstriction after allergen challenge of non-anesthetised guinea-pigs, Am Rev Resp Dis, 137, 548, 10.1164/ajrccm/137.3.548
Kimura, 1973, Basophils in bronchial asthma with reference to reagin-type allergy, Clin Allergy, 3, 195, 10.1111/j.1365-2222.1973.tb01321.x
Gulbenkian, 1990, Anaphylactic challenge causes eosinophil accumulation in bronchoalveolar lavage fluid of guinea-pigs, Am Rev Resp Dis, 142, 680, 10.1164/ajrccm/142.3.680
Kings, 1990, Human recombinant lymphokines and cytokines induce pulmonary eosinophilia in the guinea-pig which is inhibited by ketotifen and AH 21-132, Int Arch Allergy Appl Immunol, 91, 354, 10.1159/000235141
Etienne, 1989, Modulation by drugs of eosinophil recruitment induced by immune challenge in the rat, Int Arch All Appl Immunol, 88, 216, 10.1159/000234790
Touvay, 1989, Effect of cyclosporin A and the platelet-activating factor (PAF) antagonist, BN 52021, on PAF- and antigen-induced bronchoconstriction in the guinea-pig, Biochem Biophys Res Comm, 163, 118, 10.1016/0006-291X(89)92107-4
Arima, 1990, Cyclosporin A inhibits allergen-induced late asthmatic response and increase of airway hyperresponsiveness in guinea-pigs, Am Rev Resp Dis, 141, A475
Yoshimura, 1989, Effect of a new immunosuppressant agent, FK506, on human lymphocyte responses in vitro: I. FK506 inhibits the expression of alloantigen-activated suppressor cells as well as the induction of alloreactivity, Transplantation, 47, 351, 10.1097/00007890-198902000-00034